Neal Walker - Net Worth and Insider Trading
Neal Walker Net Worth
The estimated net worth of Neal Walker is at least $1 Million dollars as of 2024-05-11. Neal Walker is the Director of Aclaris Therapeutics Inc and owns about 1,273,202 shares of Aclaris Therapeutics Inc (ACRS) stock worth over $1 Million. Details can be seen in Neal Walker's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Neal Walker has not made any transactions after 2023-03-03 and currently still holds the listed stock(s).
Transaction Summary of Neal Walker
Neal Walker Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Neal Walker owns 2 companies in total, including Aclaris Therapeutics Inc (ACRS) , and Aldeyra Therapeutics Inc (ALDX) .
Click here to see the complete history of Neal Walker’s form 4 insider trades.
Insider Ownership Summary of Neal Walker
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACRS | Aclaris Therapeutics Inc | 2023-03-03 | director & President and CEO |
| ALDX | Aldeyra Therapeutics Inc | 2016-06-09 | director |
Neal Walker Latest Holdings Summary
Neal Walker currently owns a total of 1 stock. Neal Walker owns 1,273,202 shares of Aclaris Therapeutics Inc (ACRS) as of March 3, 2023, with a value of $1 Million.
Latest Holdings of Neal Walker
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics Inc | 2023-03-03 | 1,273,202 | 1.17 | 1,489,646 |
Holding Weightings of Neal Walker
Neal Walker Form 4 Trading Tracker
According to the SEC Form 4 filings, Neal Walker has made a total of 7 transactions in Aclaris Therapeutics Inc (ACRS) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Aclaris Therapeutics Inc is the sale of 59,240 shares on March 3, 2023, which brought Neal Walker around $740,500.
Insider Trading History of Neal Walker
- 1
Neal Walker Trading Performance
GuruFocus tracks the stock performance after each of Neal Walker's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Neal Walker is 24.55%. GuruFocus also compares Neal Walker's trading performance to market benchmark return within the same time period. The performance of stocks bought by Neal Walker within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Neal Walker's insider trading performs compared to the benchmark.
Performance of Neal Walker
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.04 | | | | | |
| Relative Return to S&P 500(%) | 8.02 | | | | | |
Neal Walker Ownership Network
Neal Walker Owned Company Details
What does Aclaris Therapeutics Inc do?
Who are the key executives at Aclaris Therapeutics Inc?
Neal Walker is the director & President and CEO of Aclaris Therapeutics Inc. Other key executives at Aclaris Therapeutics Inc include Chief Scientific Officer Joseph Monahan , Chief Financial Officer Kevin Balthaser , and Chief Business Officer James Loerop .
Aclaris Therapeutics Inc (ACRS) Insider Trades Summary
Over the past 18 months, Neal Walker made 3 insider transaction in Aclaris Therapeutics Inc (ACRS) with a net sale of 129,240. Other recent insider transactions involving Aclaris Therapeutics Inc (ACRS) include a net sale of 53,837 shares made by Joseph Monahan , a net purchase of 12,800 shares made by Douglas J. Manion , and a net purchase of 10,438 shares made by James Loerop .
In summary, during the past 3 months, insiders sold 0 shares of Aclaris Therapeutics Inc (ACRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 243,164 shares of Aclaris Therapeutics Inc (ACRS) were sold and 36,995 shares were bought by its insiders, resulting in a net sale of 206,169 shares.
Aclaris Therapeutics Inc (ACRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aclaris Therapeutics Inc Insider Transactions
Neal Walker Mailing Address
Above is the net worth, insider trading, and ownership report for Neal Walker. You might contact Neal Walker via mailing address: 15 New England Executive Park, Burlington Ma 01803.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
